We are excited to share our latest edition of the Frier Levitt Life Sciences Newsletter, a guide filled with vital perspectives on the constantly changing field of pharmacy law. We are committed to providing you with the latest developments within the industry, and this edition is packed with essential updates on the most pressing topics.
In this edition, we cover a wide range of timely and paramount headlines, including:
- SPOTLIGHT: Tirzepatide Compounding – Navigating Legal and Regulatory Shifts
- Federal Trade Commission (FTC) Files Complaint Against Three Largest PBMS and their GPOs
- N.J.’s January 1st PBM Law Change Opens Competitive Edge to Savvy Value-Based Providers With Shared Savings Arrangements
- Growing Trend in Audits of Copay Coupon Claims by Pharmaceutical Manufacturers
- Drug Supply Chain Security Act (DSCSA)- What the November 27, 2024 End of FDA Enforcement Discretion Means For Pharmacies
- Arkansas Announces Nearly $1.5 Million in Penalties Against Major PBMs Due to Below Cost Reimbursements
- Navigating Litigation and Intellectual Property in 503A Compounding
- Compliant Approaches to Medication Adherence
- CAPITATED PROVIDER ALERT: Beware Relationships, Direct or Indirect, With Insurance Agents and Brokerages Seeking to Increase Your Patient Membership Size
- Federal Court Strikes Down Whistleblower Provisions of the False Claims Act as Unconstitutional – Fringe Theory or Beginning of the End for Qui Tam Cases?
- Are You Being Credited for Drug Rebates in Your Value-Based Care Contracts or Short-Changed by Payors? It’s Time to Check
- Federal Court Upholds Louisiana 340B Contract Pharmacy Anti-Discrimination Law
Additionally, sign up for upcoming webinars led by our experienced healthcare and life sciences attorneys, crafted to keep you ahead of industry trends. The newsletter also includes must read attorney publications and recent client success stories.
Lastly, check out our Practice Spotlight section featuring Frier Levitt’s Government Investigations, Litigation & White-Collar Defense Group.
